MAGED2相关Bartter综合征的产前成功治疗及治疗方案与疗效综述
本文报告一例MAGED2变异导致短暂性产前Bartter综合征的孕妇,首次妊娠因羊水过多于25周早产胎死宫内,再次妊娠经绒毛膜绒毛取样确认后行三次羊水减量术,于37周6天自然分娩活婴且无电解质异常。综述31例相关病例发现,系列羊水减量者平均分娩孕周显著高于未减量者(30.71 vs 28.7周,p=0.03)。
要点
- MAGED2变异可导致短暂性产前Bartter综合征,表现为严重羊水过多,可致早产或妊娠丢失。
- 原因不明的中孕期严重羊水过多可考虑全外显子组测序。
- 推荐对MAGED2相关短暂性产前Bartter综合征进行密集超声监测和系列羊水减量术。
核心结论
- 对于原因不明的中孕期严重羊水过多,应考虑全外显子组测序;推荐对MAGED2相关短暂性产前Bartter综合征进行密集超声监测和系列羊水减量术。
研究设计与样本
- 病例报告:一名女性两次妊娠均受累于MAGED2 c.1337G>A变异;并综述已发表的MAGED2相关短暂性产前Bartter综合征病例,共汇总31例独特病例。
主要发现
- 首次妊娠于孕中期诊断轻至中度羊水过多,最终25周早产并胎死宫内;羊水样本全外显子组测序事后发现MAGED2 c.1337G>A变异。
- 再次妊娠经绒毛膜绒毛取样确认同样受累,管理为频繁超声和三次羊水减量术,于37周6天自然阴道分娩一活婴,无显性电解质异常证据,提示完全缓解。
- 综述31例中,23例行羊水减量术,18例未行羊水减量术;未行系列羊水减量者平均分娩孕周显著更低(28.7 vs 30.71周,p=0.03)。
- 未行系列羊水减量者中5/18例发生新生儿死亡,行系列羊水减量者中未观察到死亡。
关键数值与推荐
- 推荐对MAGED2相关短暂性产前Bartter综合征进行密集超声监测和系列羊水减量术。
- 对于原因不明的中孕期严重羊水过多,应考虑全外显子组测序。
临床怎么用
- 作者推荐对MAGED2相关短暂性产前Bartter综合征进行密集超声监测和系列羊水减量术;对原因不明的中孕期严重羊水过多应考虑全外显子组测序。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A new form of transient antenatal Bartter syndrome (aBS) was recently identified that is associated with the X-linked MAGED2 variant. Case reports demonstrate that this variant leads to severe polyhydramnios that may result in preterm birth or pregnancy loss. There is limited but promising evidence that amnioreductions may improve fetal outcomes in this rare condition. We report a woman with two affected pregnancies. In the first pregnancy, the patient was diagnosed with mild-to-moderate polyhydramnios in the second trimester that ultimately resulted in preterm labor and delivery at 25 weeks with fetal demise. Whole exome sequencing of the amniotic fluid sample resulted after the pregnancy loss and revealed a c.1337G>A MAGED2 variant that was considered diagnostically. The subsequent pregnancy was confirmed by chorionic villi sampling to also be affected by this variant. The pregnancy was managed with frequent ultrasounds and three amnioreductions that resulted in spontaneous vaginal delivery at 37 weeks and 6 days of a viable newborn with no evidence of overt electrolyte abnormalities suggesting complete resolution. A detailed review of the published cases of MAGED2-related transient aBS is provided. Our review focuses on individuals who received antenatal treatment. A total of 31 unique cases of MAGED2-related transient aBS were compiled. Amnioreduction was performed in 23 cases and in 18 cases no amnioreduction was performed. The average gestational age at delivery was significantly lower in cases without serial amnioreduction (28.7 vs. 30.71 weeks, p = 0.03). Neonatal mortality was seen in 5/18 cases without serial amnioreduction, and no mortality was observed in the cases with serial amnioreduction. In cases of second trimester severe polyhydramnios without identifiable cause, whole exome sequencing should be considered. Intensive ultrasound surveillance and serial amnioreduction is recommended for the management of MAGED2-related transient aBS.
引用
- Walsh CJ, Micke K, Elfman H, et al. Successful antenatal treatment of MAGED2-related Bartter syndrome and review of treatment options and efficacy. Prenat Diagn. 2023. PMID: 38159268. doi:10.1002/pd.6508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。